Lipid Disorder News and Research

RSS

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.

24 Dec 2009

Abbott and AstraZeneca to co-promote Trilipix (fenofibric acid)

Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.

5 Jun 2009

Study shows people with mental health problems receive inadequate medical care

New research led by the University of Leicester and published this week in the British Journal of Psychiatry reveals that people with mental health problems are receiving inferior care for their medical needs.

2 Jun 2009

New hope for warding off diabetes nerve loss

A common blood test for triglycerides - a well-known cardiovascular disease risk factor - may also for the first time allow doctors to predict which patients with diabetes are more likely to develop the serious, common complication of neuropathy.

18 May 2009

Discovery of new fat-fighting pathway

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a process that controls the amount of fat that cells store for use as a back-up energy source.

1 Apr 2009

An explanation of how statins cause low rates of muscle symptoms

In the January 2009 issue of the American Journal of Medicine , Florida Atlantic University researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science and a renowned expert who has revealed numerous causal, therapeutic and preventive factors in the treatment and prevention of cardiovascular disease (CVD), most notably low-dose aspirin, explains why statins cause low rates of muscle symptoms.

9 Jan 2009

Rising triglyceride levels may be behind rising rates of obesity

A new 30-year analysis of the National Health and Nutrition Examination Survey (NHANES) database conducted by the National Lipid Association (NLA) indicates that while Americans are doing a better job of managing LDL or "bad" cholesterol, the percentage of adults with high triglycerides, a blood fat linked to heart disease, has doubled, leaving many people at risk for potentially life-threatening events such as heart attack or stroke.

10 Nov 2008

Regular meals important for the health

It is obvious to most people that our health is affected by what we eat; now, however, scientists have shown that it is also a matter of how often we eat.

21 Jul 2008

Discovery of potential target for elevated triglycerides

Diabetes researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC have identified a potential target for the development of new therapies to treat hypertriglyceridemia, a lipid disorder commonly seen in people who are obese and diabetic. Results of their study are published in the June issue of the Journal of Clinical Investigation.

26 May 2008

Spinal cord injury may not increase risk of heart disease

Americans who live with spinal cord injury do not appear to be at greater risk of developing carbohydrate and lipid disorders such as insulin resistance, diabetes, impaired glucose tolerance, and high or low blood cholesterol levels - risk factors for heart disease - than able-bodied persons, according to a new evidence review by HHS' Agency for Healthcare Research and Quality.

27 Feb 2008

New investigational combination pill improves multiple cholesterol disorders

Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.

5 Nov 2007

getABI study finds that even mild atherosclerosis in the legs increases mortality substantially

Patients with atherosclerosis in the leg arteries face a substantially increased all-cause and cardiovascular mortality risk, according to a large study presented at the European Society of Cardiology Congress in Vienna.

3 Sep 2007

Increase in prescription drug cost sharing associated with lower rates of drug treatment, adherence

A review of previous studies indicates that an increase in prescription drug cost sharing is associated with a decrease in drug spending and use of pharmacies; and for some chronic conditions, higher cost sharing is associated with greater use of expensive medical services, according to an article in the July 4 issue of JAMA: The Journal of the American Medical Association.

4 Jul 2007

Novel and important benefits of vitamin D and the problems associated with vitamin D deficiency

...will be discussed at the American Association of Clinical Endocrinologists (AACE) Fifteenth Annual Meeting and Clinical Congress, April 26-30, at the Hyatt Regency Chicago.

19 Apr 2006

Can rimonabant slow atherosclerosis?

Researchers at the University of Rochester Medical Center has announced that they have launched a study to determine whether an experimental drug, rimonabant, can slow atherosclerosis, the fatty build-up in arteries that creates heart attack risk.

2 Feb 2006

Soy oil increases heart rate variability

Taking daily supplements of fish or soy oil may improve cardiac function and protect against heart attacks in the short-term. Study results published in the April issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians, are the first to show that soy oil increases heart rate variability (HRV), a measure of cardiac autonomic function.

11 Apr 2005

Novel treatment of patients with high cholesterol focus of national meeting

Implications of recent lipid-lowering clinical trials and the specific changes to the NCEP guidelines will be the focus of discussion by Neil J. Stone, M.D., professor of clinical medicine of the Feinberg School of Medicine at Northwestern University.

6 Aug 2004